Abstract: A method of charging an electric vehicle includes receiving data indicative of the power source system voltage during charging, determining a maximum voltage limit of the power source, and setting the maximum voltage limit as the limiting voltage of the power source. The maximum voltage limit may be the maximum permissible value of the system voltage during the charging.

Abstract: Vehicle depots or yards adapted to charge multiple electric vehicles include multiple charging electrodes to simultaneously direct power to multiple electric vehicles. The charging electrodes may direct power to the electric vehicles from an utility grid or from a secondary power source.

Abstract: Vehicle depots or yards adapted to charge multiple electric vehicles include multiple charging electrodes to simultaneously direct power to multiple electric vehicles. The charging electrodes may direct power to the electric vehicles from an utility grid or from a secondary power source.

Abstract: Vehicle depots or yards adapted to charge multiple electric vehicles include multiple charging electrodes to simultaneously direct power to multiple electric vehicles. The charging electrodes may direct power to the electric vehicles from an utility grid or from a secondary power source.

Abstract: A method of charging an electric vehicle at a charging station includes electrically connecting the charging station to the vehicle. The charging station may be configured to charge the vehicle using a charging station charge protocol and the vehicle may be configured to receive the charge using a vehicle charge protocol. The vehicle receives a signal indicative of the charging station charge protocol and selects the vehicle charge protocol based on this signal. The vehicle is then charged using the selected vehicle charge protocol. While selecting, the vehicle may select one charge protocol from multiple charge protocols supported by the vehicle to match the charging station charge protocol.

Abstract: A method of charging an electric vehicle includes receiving data indicative of the power source system voltage during charging, determining a maximum voltage limit of the power source, and setting the maximum voltage limit as the limiting voltage of the power source. The maximum voltage limit may be the maximum permissible value of the system voltage during the charging.

Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.

Abstract: A method of charging an electric vehicle at a charging station includes electrically connecting the charging station to the vehicle. The charging station may be configured to charge the vehicle using a charging station charge protocol and the vehicle may be configured to receive the charge using a vehicle charge protocol. The vehicle receives a signal indicative of the charging station charge protocol and selects the vehicle charge protocol based on this signal. The vehicle is then charged using the selected vehicle charge protocol. While selecting, the vehicle may select one charge protocol from multiple charge protocols supported by the vehicle to match the charging station charge protocol.

Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.

Abstract: A method of charging an electric vehicle at a charging station includes electrically connecting the charging station to the vehicle. The charging station may be configured to charge the vehicle using a charging station charge protocol and the vehicle may be configured to receive the charge using a vehicle charge protocol. The vehicle receives a signal indicative of the charging station charge protocol and selects the vehicle charge protocol based on this signal. The vehicle is then charged using the selected vehicle charge protocol. While selecting, the vehicle may select one charge protocol from multiple charge protocols supported by the vehicle to match the charging station charge protocol.

Abstract: Compositions, systems and methods are provided for conferring disease resistance to plant pathogens that use proteases to target plant substrate proteins inside plant cells. Briefly, the compositions, systems and methods are based upon plant substrate proteins that are targeted by pathogen-specific proteases and that activate nucleotide binding site-leucine rich repeat (NB-LRR) disease resistance proteins when cleaved by the protease. These substrate proteins are modified such that the endogenous protease recognition sequence is replaced by a protease recognition sequence specific to a different pathogen protease (i.e., a heterologous protease recognition sequence). The modified plant substrate protein therefore can be used in connection with its corresponding NB-LRR protein to activate resistance in response to cleavage by the heterologous pathogen-specific protease. When activated by the plant pathogen-specific protease, the pair initiates host defense responses thereto, including programmed cell death.